intellim Corporation
Celebrate the 15th anniversary

Accelerating Global Drug Development

We use cookies to ensure that we give you the best experience on our website. It will mean you have agreed with we would get cookies when you continue to see this website.

Regulatory Affairs/Medical Writing

intellim provides effective resolution to solve
various issues related to regulatory affairs

Medical-related regulatory affairs, Survey and Consulting Services

Our experienced regulatory experts support you regulatory affairs fro pharmaceuticals, medical devices and any other medical-related matters, survey and consulting from each phase of research to development and submission.

Our Services

Regulatory related services:

Our experienced expert support you various regulatory related matters. They understand exactly technical and market information through Database search, literature search, and hearing from external professionals.

  • Development Strategy and Regulatory Strategy Planning
  • NDA Planning and consulting on clinical trials
  • Consulting on New products development, licensing in and licensing out
  • Setting up product concept and consulting to structure alliance
  • Consulting for various matters related to generic products
Survey and others

intellim support you to conduct surveys to clinical practicians and end-users, literature search and others.

  • Hearing from clinical practicians and researchers, survey for technology trend, literature search and market research
  • Development of technology roadmap, patent map, and end-users survey

intellim’s unique Regulatory support services

intellim’s unique Regulatory support services

Our Experiences

  • Consulting to respond to Regulatory Authorities and Consulting for clinical trial
  • EU Regulation verification and Orphan drug related survey
  • Feasibility study on Korean Quasi-drug
  • US regulation for sales of Cosmetics
  • And others. Please feel free to contact us.

For more information

If you have any comments, questions, please contact us.